| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-10 23:40:41 UTC |
|---|
| Update Date | 2021-09-26 22:55:52 UTC |
|---|
| HMDB ID | HMDB0246659 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | L-Leucine-p-nitroanilide |
|---|
| Description | L-Leucine-p-nitroanilide belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Based on a literature review a significant number of articles have been published on L-Leucine-p-nitroanilide. This compound has been identified in human blood as reported by (PMID: 31557052 ). L-leucine-p-nitroanilide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically L-Leucine-p-nitroanilide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC(C)CC(N)C(=O)NC1=CC=C(C=C1)[N+]([O-])=O InChI=1S/C12H17N3O3/c1-8(2)7-11(13)12(16)14-9-3-5-10(6-4-9)15(17)18/h3-6,8,11H,7,13H2,1-2H3,(H,14,16) |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Leucine-4-nitroanilide | HMDB | | 1-Leucine-4-nitroanilide, (S)-isomer | HMDB | | 1-Leucyl-4-nitroanilide | HMDB | | 1-Leucyl-p-nitroanilide | HMDB | | L-Leucine-4-nitroanilide | HMDB |
|
|---|
| Chemical Formula | C12H17N3O3 |
|---|
| Average Molecular Weight | 251.286 |
|---|
| Monoisotopic Molecular Weight | 251.126991419 |
|---|
| IUPAC Name | 2-amino-4-methyl-N-(4-nitrophenyl)pentanamide |
|---|
| Traditional Name | 2-amino-4-methyl-N-(4-nitrophenyl)pentanamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(C)CC(N)C(=O)NC1=CC=C(C=C1)[N+]([O-])=O |
|---|
| InChI Identifier | InChI=1S/C12H17N3O3/c1-8(2)7-11(13)12(16)14-9-3-5-10(6-4-9)15(17)18/h3-6,8,11H,7,13H2,1-2H3,(H,14,16) |
|---|
| InChI Key | AXZJHDNQDSVIDR-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as leucine and derivatives. Leucine and derivatives are compounds containing leucine or a derivative thereof resulting from reaction of leucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Leucine and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Leucine or derivatives
- Alpha-amino acid amide
- Nitrobenzene
- Anilide
- Nitroaromatic compound
- N-arylamide
- Monocyclic benzene moiety
- Fatty acyl
- Fatty amide
- Benzenoid
- Organic nitro compound
- Carboxamide group
- C-nitro compound
- Secondary carboxylic acid amide
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic oxoazanium
- Allyl-type 1,3-dipolar organic compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organopnictogen compound
- Primary aliphatic amine
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Primary amine
- Hydrocarbon derivative
- Amine
- Organic zwitterion
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 12.1558 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.6 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1446.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 290.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 117.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 165.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 63.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 352.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 452.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 91.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 891.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 350.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1056.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 333.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 304.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 337.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 444.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 85.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| L-Leucine-p-nitroanilide,1TMS,isomer #1 | CC(C)CC(N[Si](C)(C)C)C(=O)NC1=CC=C([N+](=O)[O-])C=C1 | 2403.9 | Semi standard non polar | 33892256 | | L-Leucine-p-nitroanilide,1TMS,isomer #1 | CC(C)CC(N[Si](C)(C)C)C(=O)NC1=CC=C([N+](=O)[O-])C=C1 | 2245.8 | Standard non polar | 33892256 | | L-Leucine-p-nitroanilide,1TMS,isomer #1 | CC(C)CC(N[Si](C)(C)C)C(=O)NC1=CC=C([N+](=O)[O-])C=C1 | 3019.6 | Standard polar | 33892256 | | L-Leucine-p-nitroanilide,1TMS,isomer #2 | CC(C)CC(N)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C | 2209.3 | Semi standard non polar | 33892256 | | L-Leucine-p-nitroanilide,1TMS,isomer #2 | CC(C)CC(N)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C | 2187.2 | Standard non polar | 33892256 | | L-Leucine-p-nitroanilide,1TMS,isomer #2 | CC(C)CC(N)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C | 3062.4 | Standard polar | 33892256 | | L-Leucine-p-nitroanilide,2TMS,isomer #1 | CC(C)CC(C(=O)NC1=CC=C([N+](=O)[O-])C=C1)N([Si](C)(C)C)[Si](C)(C)C | 2497.8 | Semi standard non polar | 33892256 | | L-Leucine-p-nitroanilide,2TMS,isomer #1 | CC(C)CC(C(=O)NC1=CC=C([N+](=O)[O-])C=C1)N([Si](C)(C)C)[Si](C)(C)C | 2383.9 | Standard non polar | 33892256 | | L-Leucine-p-nitroanilide,2TMS,isomer #1 | CC(C)CC(C(=O)NC1=CC=C([N+](=O)[O-])C=C1)N([Si](C)(C)C)[Si](C)(C)C | 2846.4 | Standard polar | 33892256 | | L-Leucine-p-nitroanilide,2TMS,isomer #2 | CC(C)CC(N[Si](C)(C)C)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C | 2202.2 | Semi standard non polar | 33892256 | | L-Leucine-p-nitroanilide,2TMS,isomer #2 | CC(C)CC(N[Si](C)(C)C)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C | 2258.3 | Standard non polar | 33892256 | | L-Leucine-p-nitroanilide,2TMS,isomer #2 | CC(C)CC(N[Si](C)(C)C)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C | 2643.2 | Standard polar | 33892256 | | L-Leucine-p-nitroanilide,3TMS,isomer #1 | CC(C)CC(C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2386.6 | Semi standard non polar | 33892256 | | L-Leucine-p-nitroanilide,3TMS,isomer #1 | CC(C)CC(C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2397.9 | Standard non polar | 33892256 | | L-Leucine-p-nitroanilide,3TMS,isomer #1 | CC(C)CC(C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2532.7 | Standard polar | 33892256 | | L-Leucine-p-nitroanilide,1TBDMS,isomer #1 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)NC1=CC=C([N+](=O)[O-])C=C1 | 2645.4 | Semi standard non polar | 33892256 | | L-Leucine-p-nitroanilide,1TBDMS,isomer #1 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)NC1=CC=C([N+](=O)[O-])C=C1 | 2464.2 | Standard non polar | 33892256 | | L-Leucine-p-nitroanilide,1TBDMS,isomer #1 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)NC1=CC=C([N+](=O)[O-])C=C1 | 3040.8 | Standard polar | 33892256 | | L-Leucine-p-nitroanilide,1TBDMS,isomer #2 | CC(C)CC(N)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C(C)(C)C | 2513.1 | Semi standard non polar | 33892256 | | L-Leucine-p-nitroanilide,1TBDMS,isomer #2 | CC(C)CC(N)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C(C)(C)C | 2392.8 | Standard non polar | 33892256 | | L-Leucine-p-nitroanilide,1TBDMS,isomer #2 | CC(C)CC(N)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C(C)(C)C | 3095.8 | Standard polar | 33892256 | | L-Leucine-p-nitroanilide,2TBDMS,isomer #1 | CC(C)CC(C(=O)NC1=CC=C([N+](=O)[O-])C=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2975.4 | Semi standard non polar | 33892256 | | L-Leucine-p-nitroanilide,2TBDMS,isomer #1 | CC(C)CC(C(=O)NC1=CC=C([N+](=O)[O-])C=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2778.6 | Standard non polar | 33892256 | | L-Leucine-p-nitroanilide,2TBDMS,isomer #1 | CC(C)CC(C(=O)NC1=CC=C([N+](=O)[O-])C=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2922.2 | Standard polar | 33892256 | | L-Leucine-p-nitroanilide,2TBDMS,isomer #2 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C(C)(C)C | 2730.9 | Semi standard non polar | 33892256 | | L-Leucine-p-nitroanilide,2TBDMS,isomer #2 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C(C)(C)C | 2683.1 | Standard non polar | 33892256 | | L-Leucine-p-nitroanilide,2TBDMS,isomer #2 | CC(C)CC(N[Si](C)(C)C(C)(C)C)C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C(C)(C)C | 2806.6 | Standard polar | 33892256 | | L-Leucine-p-nitroanilide,3TBDMS,isomer #1 | CC(C)CC(C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3140.3 | Semi standard non polar | 33892256 | | L-Leucine-p-nitroanilide,3TBDMS,isomer #1 | CC(C)CC(C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2973.9 | Standard non polar | 33892256 | | L-Leucine-p-nitroanilide,3TBDMS,isomer #1 | CC(C)CC(C(=O)N(C1=CC=C([N+](=O)[O-])C=C1)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2760.3 | Standard polar | 33892256 |
|
|---|